Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation
The autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal dominant HIES because of signal transducer and activator of transcription 3 (STAT3) mutations, including recurrent infections and mucocutaneous candidiasi...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 138; no. 5; pp. 1384 - 1394.e2 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
St. Louis
Elsevier Inc
01.11.2016
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal dominant HIES because of signal transducer and activator of transcription 3 (STAT3) mutations, including recurrent infections and mucocutaneous candidiasis, which are suggestive of TH17 cell dysfunction. The mechanisms underlying this phenotypic overlap are unclear.
We sought to elucidate common mechanisms operating in the different forms of HIES.
We analyzed the differentiation of CD4+ TH cell subsets in control and DOCK8-deficient subjects. We also examined the role of DOCK8 in regulating STAT3 activation in T cells. TH cell differentiation was analyzed by ELISA, flow cytometry, and real-time PCR measurements of cytokines and TH cell transcription factors. The interaction of DOCK8 and STAT3 signaling pathways was examined by using flow cytometry, immunofluorescence, coimmunoprecipitation, and gene expression analysis.
There was a profound block in the differentiation of DOCK8-deficient naive CD4+ T cells into TH17 cells. A missense mutation that disrupts DOCK8 guanine nucleotide exchange factor (GEF) activity while sparing protein expression also impaired TH17 cell differentiation. DOCK8 constitutively associated with STAT3 independent of GEF activity, whereas it regulated STAT3 phosphorylation in a GEF activity–dependent manner. DOCK8 also promoted STAT3 translocation to the nucleus and induction of STAT3-dependent gene expression.
DOCK8 interacts with STAT3 and regulates its activation and the outcome of STAT3-dependent TH17 differentiation. These findings might explain the phenotypic overlap between DOCK8 deficiency and autosomal dominant HIES. |
---|---|
AbstractList | The autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal dominant HIES because of signal transducer and activator of transcription 3 (STAT3) mutations, including recurrent infections and mucocutaneous candidiasis, which are suggestive of TH17 cell dysfunction. The mechanisms underlying this phenotypic overlap are unclear.
We sought to elucidate common mechanisms operating in the different forms of HIES.
We analyzed the differentiation of CD4+ TH cell subsets in control and DOCK8-deficient subjects. We also examined the role of DOCK8 in regulating STAT3 activation in T cells. TH cell differentiation was analyzed by ELISA, flow cytometry, and real-time PCR measurements of cytokines and TH cell transcription factors. The interaction of DOCK8 and STAT3 signaling pathways was examined by using flow cytometry, immunofluorescence, coimmunoprecipitation, and gene expression analysis.
There was a profound block in the differentiation of DOCK8-deficient naive CD4+ T cells into TH17 cells. A missense mutation that disrupts DOCK8 guanine nucleotide exchange factor (GEF) activity while sparing protein expression also impaired TH17 cell differentiation. DOCK8 constitutively associated with STAT3 independent of GEF activity, whereas it regulated STAT3 phosphorylation in a GEF activity–dependent manner. DOCK8 also promoted STAT3 translocation to the nucleus and induction of STAT3-dependent gene expression.
DOCK8 interacts with STAT3 and regulates its activation and the outcome of STAT3-dependent TH17 differentiation. These findings might explain the phenotypic overlap between DOCK8 deficiency and autosomal dominant HIES. Background The autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal dominant HIES because of signal transducer and activator of transcription 3 (STAT3) mutations, including recurrent infections and mucocutaneous candidiasis, which are suggestive of TH17 cell dysfunction. The mechanisms underlying this phenotypic overlap are unclear. Objective We sought to elucidate common mechanisms operating in the different forms of HIES. Methods We analyzed the differentiation of CD4+ TH cell subsets in control and DOCK8-deficient subjects. We also examined the role of DOCK8 in regulating STAT3 activation in T cells. TH cell differentiation was analyzed by ELISA, flow cytometry, and real-time PCR measurements of cytokines and TH cell transcription factors. The interaction of DOCK8 and STAT3 signaling pathways was examined by using flow cytometry, immunofluorescence, coimmunoprecipitation, and gene expression analysis. Results There was a profound block in the differentiation of DOCK8-deficient naive CD4+ T cells into TH17 cells. A missense mutation that disrupts DOCK8 guanine nucleotide exchange factor (GEF) activity while sparing protein expression also impaired TH17 cell differentiation. DOCK8 constitutively associated with STAT3 independent of GEF activity, whereas it regulated STAT3 phosphorylation in a GEF activity-dependent manner. DOCK8 also promoted STAT3 translocation to the nucleus and induction of STAT3-dependent gene expression. Conclusion DOCK8 interacts with STAT3 and regulates its activation and the outcome of STAT3-dependent TH17 differentiation. These findings might explain the phenotypic overlap between DOCK8 deficiency and autosomal dominant HIES. BACKGROUNDThe autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal dominant HIES because of signal transducer and activator of transcription 3 (STAT3) mutations, including recurrent infections and mucocutaneous candidiasis, which are suggestive of TH17 cell dysfunction. The mechanisms underlying this phenotypic overlap are unclear.OBJECTIVEWe sought to elucidate common mechanisms operating in the different forms of HIES.METHODSWe analyzed the differentiation of CD4+ TH cell subsets in control and DOCK8-deficient subjects. We also examined the role of DOCK8 in regulating STAT3 activation in T cells. TH cell differentiation was analyzed by ELISA, flow cytometry, and real-time PCR measurements of cytokines and TH cell transcription factors. The interaction of DOCK8 and STAT3 signaling pathways was examined by using flow cytometry, immunofluorescence, coimmunoprecipitation, and gene expression analysis.RESULTSThere was a profound block in the differentiation of DOCK8-deficient naive CD4+ T cells into TH17 cells. A missense mutation that disrupts DOCK8 guanine nucleotide exchange factor (GEF) activity while sparing protein expression also impaired TH17 cell differentiation. DOCK8 constitutively associated with STAT3 independent of GEF activity, whereas it regulated STAT3 phosphorylation in a GEF activity-dependent manner. DOCK8 also promoted STAT3 translocation to the nucleus and induction of STAT3-dependent gene expression.CONCLUSIONDOCK8 interacts with STAT3 and regulates its activation and the outcome of STAT3-dependent TH17 differentiation. These findings might explain the phenotypic overlap between DOCK8 deficiency and autosomal dominant HIES. Background The autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal dominant HIES because of signal transducer and activator of transcription 3(STAT3)mutations, including recurrent infections and mucocutaneous candidiasis, which are suggestive of TH17 cell dysfunction. The mechanisms underlying this phenotypic overlap are unclear. Objective We sought to elucidate common mechanisms operating in the different forms of HIES. Methods We analyzed the differentiation of CD4+THcell subsets in control and DOCK8-deficient subjects. We also examined the role of DOCK8 in regulating STAT3 activation in T cells. THcell differentiation was analyzed by ELISA, flow cytometry, and real-time PCR measurements of cytokines and THcell transcription factors. The interaction of DOCK8 and STAT3 signaling pathways was examined by using flow cytometry, immunofluorescence, coimmunoprecipitation, and gene expression analysis. Results There was a profound block in the differentiation of DOCK8-deficient naive CD4+T cells into TH17 cells. A missense mutation that disrupts DOCK8 guanine nucleotide exchange factor (GEF) activity while sparing protein expression also impaired TH17 cell differentiation. DOCK8 constitutively associated with STAT3 independent of GEF activity, whereas it regulated STAT3 phosphorylation in a GEF activity-dependent manner. DOCK8 also promoted STAT3 translocation to the nucleus and induction of STAT3-dependent gene expression. Conclusion DOCK8 interacts with STAT3 and regulates its activation and the outcome of STAT3-dependent TH17 differentiation. These findings might explain the phenotypic overlap between DOCK8 deficiency and autosomal dominant HIES. |
Author | Ramesh, Narayanaswamy Charbonnier, Louis Marie Wu, Hao Keles, Sevgi Perez-Atayde, Antonio Kutukculer, Necil Geha, Raif S. Genel, Ferah Chatila, Talal A. Gulez, Nesrin Kabaleeswaran, Venkataraman Al-Herz, Waleed Reisli, Ismail Karaca, Neslihan E. |
Author_xml | – sequence: 1 givenname: Sevgi orcidid: 0000-0002-4351-8200 surname: Keles fullname: Keles, Sevgi organization: Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass – sequence: 2 givenname: Louis Marie surname: Charbonnier fullname: Charbonnier, Louis Marie organization: Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass – sequence: 3 givenname: Venkataraman surname: Kabaleeswaran fullname: Kabaleeswaran, Venkataraman organization: Program in Molecular and Cellular Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass – sequence: 4 givenname: Ismail surname: Reisli fullname: Reisli, Ismail organization: Division of Pediatric Immunology and Allergy, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey – sequence: 5 givenname: Ferah surname: Genel fullname: Genel, Ferah organization: Division of Pediatric Immunology, Behcet Uz State Hospital, Izmir, Turkey – sequence: 6 givenname: Nesrin surname: Gulez fullname: Gulez, Nesrin organization: Division of Pediatric Immunology, Behcet Uz State Hospital, Izmir, Turkey – sequence: 7 givenname: Waleed surname: Al-Herz fullname: Al-Herz, Waleed organization: Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait – sequence: 8 givenname: Narayanaswamy surname: Ramesh fullname: Ramesh, Narayanaswamy organization: Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass – sequence: 9 givenname: Antonio surname: Perez-Atayde fullname: Perez-Atayde, Antonio organization: Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, Mass – sequence: 10 givenname: Neslihan E. surname: Karaca fullname: Karaca, Neslihan E. organization: Division of Pediatric Immunology, Ege University, Izmir, Turkey – sequence: 11 givenname: Necil surname: Kutukculer fullname: Kutukculer, Necil organization: Division of Pediatric Immunology, Ege University, Izmir, Turkey – sequence: 12 givenname: Hao surname: Wu fullname: Wu, Hao organization: Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass – sequence: 13 givenname: Raif S. surname: Geha fullname: Geha, Raif S. organization: Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass – sequence: 14 givenname: Talal A. surname: Chatila fullname: Chatila, Talal A. email: talal.chatila@childrens.harvard.edu organization: Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass |
BookMark | eNqNksuOFCEUhokZE3tGX8AViRs3XQJVFIVxY8bLmEziZlwTCg4TaqqhBXqSfoV5Cp_FJ5Pqdja9GN1wCd93AufnHJ2FGACh15Q0lND-3dRM2viG1XVDuoaw9hlaUSLFuh8YP0MrQiRd96KTL9B5zhOp-3aQK_TwCaw3usSEo8NmX-KdD5B9xgNOcLubdYGMs78NesYl6ZDtzkDCOlisTfH3j-rhzCS_LT4G3D4eLpuF3aa4iUupmysqfv8yMM_YeucgQSj-wL1Ez52eM7z6O1-gH18-31xera-_f_12-fF6bTjnpY5udNRqYlsyStrqngujuWCc8dFpNmphuWg5M303CJCm1cYSTTpHwBo3thfo7bFuvdPPHeSiNj4vF9IB4i4rOnR9Rzs29P-Bsl4QKQmv6JsTdIq7VLu2UK3gg-ykrNRwpEyKOSdwyvhyeH3tn58VJWrJU01qyVMteSrSqZpnVdmJuk1-o9P-aenDUYLa0HsPSWXjIZgaegJTlI3-af39iW5mH-p_me9g_y_5D6040l8 |
CitedBy_id | crossref_primary_10_2217_frd_2020_0003 crossref_primary_10_1111_all_14081 crossref_primary_10_1016_j_clim_2024_110384 crossref_primary_10_1042_BST20200468 crossref_primary_10_1038_s41577_021_00500_7 crossref_primary_10_1007_s00335_018_9767_2 crossref_primary_10_1016_j_mucimm_2023_12_001 crossref_primary_10_1007_s11033_022_07865_5 crossref_primary_10_4103_ipcares_ipcares_156_24 crossref_primary_10_1016_j_anai_2017_07_011 crossref_primary_10_1097_MD_0000000000020866 crossref_primary_10_1186_s12881_019_0837_4 crossref_primary_10_1002_mco2_747 crossref_primary_10_1172_jci_insight_127527 crossref_primary_10_1007_s10875_017_0451_1 crossref_primary_10_1038_s41467_018_03670_6 crossref_primary_10_1084_jem_20160576 crossref_primary_10_3389_fimmu_2021_695596 crossref_primary_10_1016_j_clim_2023_109681 crossref_primary_10_1126_science_aaw6433 crossref_primary_10_1111_imcb_12243 crossref_primary_10_1038_cmi_2017_9 crossref_primary_10_1007_s12026_023_09359_3 crossref_primary_10_1016_j_clim_2017_06_003 crossref_primary_10_1172_JCI124604 crossref_primary_10_1016_j_coi_2022_102277 crossref_primary_10_3389_fimmu_2024_1507494 crossref_primary_10_1016_j_coi_2023_102298 crossref_primary_10_3390_cells9092044 crossref_primary_10_1080_1744666X_2024_2352479 crossref_primary_10_1097_MOP_0000000000000948 crossref_primary_10_1111_sji_13276 crossref_primary_10_1007_s10875_024_01777_8 crossref_primary_10_1111_imr_12716 crossref_primary_10_4049_jimmunol_1700751 crossref_primary_10_1016_j_clim_2018_07_011 crossref_primary_10_1111_imr_12723 crossref_primary_10_1016_j_jaci_2018_01_042 crossref_primary_10_1177_2042018820935771 crossref_primary_10_3390_cancers17010055 crossref_primary_10_1111_imcb_12209 crossref_primary_10_1111_petr_13545 crossref_primary_10_1126_sciimmunol_aat9779 crossref_primary_10_1016_j_clim_2017_08_020 crossref_primary_10_1093_cei_uxad007 crossref_primary_10_1097_MOH_0000000000000296 crossref_primary_10_1111_pai_14260 crossref_primary_10_1111_1346_8138_15955 crossref_primary_10_3389_fimmu_2022_1057679 crossref_primary_10_1002_eji_201847960 crossref_primary_10_3389_fphar_2022_1065029 crossref_primary_10_1126_sciimmunol_aat4941 crossref_primary_10_1016_j_it_2016_12_002 crossref_primary_10_1159_000509717 crossref_primary_10_1016_j_mce_2017_01_035 crossref_primary_10_1097_INF_0000000000004321 crossref_primary_10_1038_s41590_020_0795_1 crossref_primary_10_1016_j_jaci_2017_07_023 crossref_primary_10_1097_MOP_0000000000000697 crossref_primary_10_4049_jimmunol_2001294 crossref_primary_10_1016_j_jaip_2023_04_015 crossref_primary_10_3389_fimmu_2019_02108 crossref_primary_10_1002_JLB_1MR0520_221RR crossref_primary_10_1038_s41467_021_27273_w crossref_primary_10_3389_fped_2020_604725 crossref_primary_10_3389_fped_2024_1389650 |
Cites_doi | 10.1056/NEJM199903043400904 10.1182/blood-2012-01-407098 10.1084/jem.20030471 10.1016/j.jaci.2014.03.025 10.1073/pnas.1016147107 10.1084/jem.20080218 10.1038/nature06096 10.1038/nature05970 10.1038/nature06764 10.1016/j.jaci.2014.02.023 10.1016/j.jaci.2009.10.038 10.1128/MCB.17.8.4677 10.1111/j.1365-2249.2006.03251.x 10.1107/S0907444904019158 10.1016/S0022-3476(03)00449-9 10.1056/NEJMoa1413462 10.1074/jbc.M413187200 10.1084/jem.20141307 10.1126/science.8140422 10.1073/pnas.0611665104 10.1038/nature04753 10.1128/MCB.22.16.5662-5668.2002 10.4049/jimmunol.1202792 10.1016/j.jaci.2014.03.032 10.1084/jem.20080321 10.1016/j.jaci.2012.12.1568 10.1016/j.jaci.2014.07.042 10.1056/NEJMoa073687 10.1111/j.1749-6632.2011.06295.x 10.1016/j.tcb.2007.05.001 10.1016/j.clim.2014.04.005 10.1038/nmeth0410-248 10.1007/s11010-006-9137-3 10.1038/ni.2305 10.1126/science.1174468 10.1056/NEJMoa0905506 10.1038/ncomms5603 10.1016/j.clim.2012.03.002 10.1016/j.jaci.2014.12.1945 10.1016/j.jaci.2009.10.059 10.1155/2010/397291 10.1007/s10875-014-0126-0 10.1016/j.jaci.2009.05.004 10.1074/jbc.M111.236455 10.1101/gr.212802 10.1016/j.jaci.2008.04.037 |
ContentType | Journal Article |
Copyright | 2016 American Academy of Allergy, Asthma & Immunology Copyright Elsevier Limited Nov 01, 2016 |
Copyright_xml | – notice: 2016 American Academy of Allergy, Asthma & Immunology – notice: Copyright Elsevier Limited Nov 01, 2016 |
DBID | AAYXX CITATION 7SS 7T5 H94 K9. NAPCQ 7X8 |
DOI | 10.1016/j.jaci.2016.04.023 |
DatabaseName | CrossRef Entomology Abstracts (Full archive) Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef Entomology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic Entomology Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6825 |
EndPage | 1394.e2 |
ExternalDocumentID | 4244338231 10_1016_j_jaci_2016_04_023 S0091674916303529 |
GrantInformation_xml | – fundername: Scientific and Technological Research Council grantid: 1059B191300622 – fundername: National Institutes of Health grantid: 5R01AI065617 funderid: http://dx.doi.org/10.13039/100000002 – fundername: T. A. Chatila grantid: 5R01AI065617 |
GroupedDBID | --- --K --M -~X .1- .55 .FO .GJ .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8F7 8FE 8FH 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN ADXHL AEBSH AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CAG CJTIS COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDU HMK HMO HVGLF HZ~ IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M41 MO0 N4W N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OHT OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW WUQ X7M XFW YOC YQI YQJ Z5R ZGI ZXP ZY1 ~02 ~G- ~KM AACTN RIG AAYXX AGRNS CITATION 7SS 7T5 H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c555t-c5fbf1da0d30b913a657ca572525bfa2ba7d57352c6487e9c3acd0a04f0edcfb3 |
IEDL.DBID | .~1 |
ISSN | 0091-6749 |
IngestDate | Fri Jul 11 08:47:45 EDT 2025 Fri Jul 11 09:22:17 EDT 2025 Wed Aug 13 06:11:03 EDT 2025 Tue Jul 01 00:47:22 EDT 2025 Thu Apr 24 23:02:35 EDT 2025 Sun Apr 06 06:53:22 EDT 2025 Tue Aug 26 16:32:03 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | suppressor of cytokine signaling 3 IL-6R AD DOCK8 GEF signal transducer and activator of transcription 3 SOCS ChIP hyper-IgE syndrome dedicator of cytokinesis 8 HIES AR Na3VO4 STAT guanine nucleotide exchange factor Cell division cycle 42 mucocutaneous candidiasis pSTAT3 Rac1 TH17 GAPDH WT Cdc42 RORγt |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c555t-c5fbf1da0d30b913a657ca572525bfa2ba7d57352c6487e9c3acd0a04f0edcfb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4351-8200 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5099100 |
PQID | 1837589499 |
PQPubID | 105664 |
ParticipantIDs | proquest_miscellaneous_1846414286 proquest_miscellaneous_1826709905 proquest_journals_1837589499 crossref_citationtrail_10_1016_j_jaci_2016_04_023 crossref_primary_10_1016_j_jaci_2016_04_023 elsevier_sciencedirect_doi_10_1016_j_jaci_2016_04_023 elsevier_clinicalkey_doi_10_1016_j_jaci_2016_04_023 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2016 2016-11-00 20161101 |
PublicationDateYYYYMMDD | 2016-11-01 |
PublicationDate_xml | – month: 11 year: 2016 text: November 2016 |
PublicationDecade | 2010 |
PublicationPlace | St. Louis |
PublicationPlace_xml | – name: St. Louis |
PublicationTitle | Journal of allergy and clinical immunology |
PublicationYear | 2016 |
Publisher | Elsevier Inc Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
References | Grimbacher, Holland, Gallin, Greenberg, Hill, Malech (bib17) 1999; 340 Kulkarni, Yang, Zhang, Barford (bib31) 2011; 286 Debidda, Wang, Zang, Poli, Zheng (bib42) 2005; 280 Su, Jing, Zhang (bib45) 2011; 1246 de Beaucoudrey, Puel, Filipe-Santos, Cobat, Ghandil, Chrabieh (bib21) 2008; 205 Al Khatib, Keles, Garcia-Lloret, Karakoc-Aydiner, Reisli, Artac (bib18) 2009; 124 Ma, Chew, Simpson, Priyadarshi, Wong, Grimbacher (bib22) 2008; 205 Korn, Bettelli, Gao, Awasthi, Jager, Strom (bib36) 2007; 448 Dobbs, Dominguez Conde, Zhang, Parolini, Audry, Chou (bib27) 2015; 372 Ng, Henikoff (bib32) 2002; 12 Adzhubei, Schmidt, Peshkin, Ramensky, Gerasimova, Bork (bib33) 2010; 7 Renner, Rylaarsdam, Anover-Sombke, Rack, Reichenbach, Carey (bib24) 2008; 122 Delano (bib26) 2002 ten Hoeve, de Jesus Ibarra-Sanchez, Fu, Zhu, Tremblay, David (bib40) 2002; 22 Renner, Puck, Holland, Schmitt, Weiss, Frosch (bib1) 2004; 144 Ham, Guerrier, Kim, Schoon, Anderson, Hamann (bib9) 2013; 190 Li, Zhou, Wandstrat, Carr-Johnson, Branch, Karp (bib28) 2007; 147 Janssen, Morbach, Ullas, Bannock, Massad, Menard (bib12) 2014; 134 Jabara, McDonald, Janssen, Massaad, Ramesh, Borzutzky (bib14) 2012; 13 Sasse, Hemmann, Schwartz, Schniertshauer, Heesel, Landgraf (bib39) 1997; 17 Woellner, Gertz, Schaffer, Lagos, Perro, Glocker (bib44) 2010; 125 McGhee, Chatila (bib6) 2010; 29 Holland, DeLeo, Elloumi, Hsu, Uzel, Brodsky (bib19) 2007; 357 Yang, Zhang, Roe, Marshall, Barford (bib30) 2009; 325 Pai, de Boer, Massaad, Chatila, Keles, Jabara (bib34) 2014; 134 Aydin, Kilic, Aytekin, Kumar, Porras, Kainulainen (bib4) 2015; 35 Primary immunodeficiency diseases (bib29) 1999; 118 Mizesko, Banerjee, Monaco-Shawver, Mace, Bernal, Sawalle-Belohradsky (bib8) 2013; 131 Cote, Vuori (bib5) 2007; 17 Al-Zahrani, Raddadi, Massaad, Keles, Jabara, Chatila (bib15) 2014; 153 Singh, Eken, Fry, Bettelli, Oukka (bib43) 2014; 5 Minegishi, Saito, Tsuchiya, Tsuge, Takada, Hara (bib20) 2007; 448 Zhang, Davis, Lamborn, Freeman, Jing, Favreau (bib2) 2009; 361 Al-Herz, Ragupathy, Massaad, Al-Attiyah, Nanda, Engelhardt (bib10) 2012; 143 Bettelli, Carrier, Gao, Korn, Strom, Oukka (bib35) 2006; 441 Zhong, Wen, Darnell (bib38) 1994; 264 Keles, Jabara, Reisli, McDonald, Barlan, Hanna-Wakim (bib16) 2014; 133 Zhang, Badgwell, Bevers, Schlessinger, Murray, Levy (bib37) 2006; 288 Harada, Tanaka, Terasawa, Pieczyk, Habiro, Katakai (bib7) 2012; 119 Engelhardt, McGhee, Winkler, Sassi, Woellner, Lopez-Herrera (bib3) 2009; 124 Emsley, Cowtan (bib25) 2004; 60 Engelhardt, Gertz, Keles, Schaffer, Sigmund, Glocker (bib11) 2015; 136 Zhang, Guo, Yu, Possemato, Chen, Zheng (bib41) 2007; 104 Jing, Zhang, Zhang, Hill, Dove, Gelfand (bib13) 2014; 133 Zhang, Dove, Hor, Murdock, Strauss-Albee, Garcia (bib46) 2014; 211 Milner, Brenchley, Laurence, Freeman, Hill, Elias (bib23) 2008; 452 Renner (10.1016/j.jaci.2016.04.023_bib1) 2004; 144 Holland (10.1016/j.jaci.2016.04.023_bib19) 2007; 357 Zhang (10.1016/j.jaci.2016.04.023_bib46) 2014; 211 Harada (10.1016/j.jaci.2016.04.023_bib7) 2012; 119 Yang (10.1016/j.jaci.2016.04.023_bibE3) 2010; 107 Zhang (10.1016/j.jaci.2016.04.023_bib2) 2009; 361 Keles (10.1016/j.jaci.2016.04.023_bib16) 2014; 133 Mizesko (10.1016/j.jaci.2016.04.023_bib8) 2013; 131 Adzhubei (10.1016/j.jaci.2016.04.023_bib33) 2010; 7 Ham (10.1016/j.jaci.2016.04.023_bib9) 2013; 190 Singh (10.1016/j.jaci.2016.04.023_bib43) 2014; 5 Grimbacher (10.1016/j.jaci.2016.04.023_bib17) 1999; 340 Emsley (10.1016/j.jaci.2016.04.023_bib25) 2004; 60 Renner (10.1016/j.jaci.2016.04.023_bib24) 2008; 122 Woellner (10.1016/j.jaci.2016.04.023_bib44) 2010; 125 Aydin (10.1016/j.jaci.2016.04.023_bib4) 2015; 35 Minegishi (10.1016/j.jaci.2016.04.023_bib20) 2007; 448 Zhang (10.1016/j.jaci.2016.04.023_bib41) 2007; 104 Milner (10.1016/j.jaci.2016.04.023_bib23) 2008; 452 Zhong (10.1016/j.jaci.2016.04.023_bib38) 1994; 264 Engelhardt (10.1016/j.jaci.2016.04.023_bibE4) 2015; 136 Janssen (10.1016/j.jaci.2016.04.023_bib12) 2014; 134 Engelhardt (10.1016/j.jaci.2016.04.023_bib11) 2015; 136 Al-Zahrani (10.1016/j.jaci.2016.04.023_bib15) 2014; 153 Cote (10.1016/j.jaci.2016.04.023_bib5) 2007; 17 Sasse (10.1016/j.jaci.2016.04.023_bib39) 1997; 17 Li (10.1016/j.jaci.2016.04.023_bib28) 2007; 147 Korn (10.1016/j.jaci.2016.04.023_bib36) 2007; 448 Blaeser (10.1016/j.jaci.2016.04.023_bibE1) 2003; 198 Keles (10.1016/j.jaci.2016.04.023_bibE6) 2014; 133 Debidda (10.1016/j.jaci.2016.04.023_bib42) 2005; 280 de Beaucoudrey (10.1016/j.jaci.2016.04.023_bib21) 2008; 205 Primary immunodeficiency diseases (10.1016/j.jaci.2016.04.023_bib29) 1999; 118 Su (10.1016/j.jaci.2016.04.023_bib45) 2011; 1246 Engelhardt (10.1016/j.jaci.2016.04.023_bibE5) 2009; 124 Ng (10.1016/j.jaci.2016.04.023_bib32) 2002; 12 Jing (10.1016/j.jaci.2016.04.023_bib13) 2014; 133 Dobbs (10.1016/j.jaci.2016.04.023_bib27) 2015; 372 Jabara (10.1016/j.jaci.2016.04.023_bib14) 2012; 13 Delano (10.1016/j.jaci.2016.04.023_bib26) 2002 Yang (10.1016/j.jaci.2016.04.023_bib30) 2009; 325 ten Hoeve (10.1016/j.jaci.2016.04.023_bib40) 2002; 22 Engelhardt (10.1016/j.jaci.2016.04.023_bib3) 2009; 124 Al-Herz (10.1016/j.jaci.2016.04.023_bib10) 2012; 143 Kulkarni (10.1016/j.jaci.2016.04.023_bib31) 2011; 286 Al Khatib (10.1016/j.jaci.2016.04.023_bibE2) 2009; 124 Bettelli (10.1016/j.jaci.2016.04.023_bib35) 2006; 441 McGhee (10.1016/j.jaci.2016.04.023_bib6) 2010; 29 Ma (10.1016/j.jaci.2016.04.023_bib22) 2008; 205 Pai (10.1016/j.jaci.2016.04.023_bib34) 2014; 134 Al Khatib (10.1016/j.jaci.2016.04.023_bib18) 2009; 124 Zhang (10.1016/j.jaci.2016.04.023_bib37) 2006; 288 |
References_xml | – volume: 133 start-page: 1667 year: 2014 end-page: 1675 ident: bib13 article-title: Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype publication-title: J Allergy Clin Immunol – volume: 452 start-page: 773 year: 2008 end-page: 776 ident: bib23 article-title: Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome publication-title: Nature – volume: 286 start-page: 25341 year: 2011 end-page: 25351 ident: bib31 article-title: Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors publication-title: J Biol Chem – volume: 35 start-page: 189 year: 2015 end-page: 198 ident: bib4 article-title: DOCK8 deficiency: clinical and immunological phenotype and treatment options—a review of 136 patients publication-title: J Clin Immunol – volume: 325 start-page: 1398 year: 2009 end-page: 1402 ident: bib30 article-title: Activation of Rho GTPases by DOCK exchange factors is mediated by a nucleotide sensor publication-title: Science – volume: 190 start-page: 3661 year: 2013 end-page: 3669 ident: bib9 article-title: Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity publication-title: J Immunol – volume: 124 start-page: 342 year: 2009 end-page: 348 ident: bib18 article-title: Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome publication-title: J Allergy Clin Immunol – volume: 136 start-page: 402 year: 2015 end-page: 412 ident: bib11 article-title: The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency publication-title: J Allergy Clin Immunol – volume: 134 start-page: 221 year: 2014 end-page: 223 ident: bib34 article-title: Flow cytometry diagnosis of dedicator of cytokinesis 8 (DOCK8) deficiency publication-title: J Allergy Clin Immunol – volume: 1246 start-page: 26 year: 2011 end-page: 33 ident: bib45 article-title: DOCK8 deficiency publication-title: Ann N Y Acad Sci – volume: 144 start-page: 93 year: 2004 end-page: 99 ident: bib1 article-title: Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity publication-title: J Pediatr – volume: 147 start-page: 60 year: 2007 end-page: 70 ident: bib28 article-title: Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes publication-title: Clin Exp Immunol – volume: 131 start-page: 840 year: 2013 end-page: 848 ident: bib8 article-title: Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency publication-title: J Allergy Clin Immunol – volume: 125 start-page: 424 year: 2010 end-page: 432.e8 ident: bib44 article-title: Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome publication-title: J Allergy Clin Immunol – volume: 13 start-page: 612 year: 2012 end-page: 620 ident: bib14 article-title: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation publication-title: Nat Immunol – volume: 448 start-page: 1058 year: 2007 end-page: 1062 ident: bib20 article-title: Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome publication-title: Nature – year: 2002 ident: bib26 article-title: The PyMol molecular graphics system – volume: 118 start-page: 1 year: 1999 end-page: 28 ident: bib29 article-title: Report of an IUIS Scientific Committee. International Union of Immunological Societies publication-title: Clin Exp Immunol – volume: 211 start-page: 2549 year: 2014 end-page: 2566 ident: bib46 article-title: DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity publication-title: J Exp Med – volume: 361 start-page: 2046 year: 2009 end-page: 2055 ident: bib2 article-title: Combined immunodeficiency associated with DOCK8 mutations publication-title: N Engl J Med – volume: 288 start-page: 179 year: 2006 end-page: 189 ident: bib37 article-title: IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain publication-title: Mol Cell Biochem – volume: 357 start-page: 1608 year: 2007 end-page: 1619 ident: bib19 article-title: STAT3 mutations in the hyper-IgE syndrome publication-title: N Engl J Med – volume: 7 start-page: 248 year: 2010 end-page: 249 ident: bib33 article-title: A method and server for predicting damaging missense mutations publication-title: Nat Methods – volume: 441 start-page: 235 year: 2006 end-page: 238 ident: bib35 article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells publication-title: Nature – volume: 29 start-page: 151 year: 2010 end-page: 156 ident: bib6 article-title: DOCK8 immune deficiency as a model for primary cytoskeletal dysfunction publication-title: Dis Markers – volume: 104 start-page: 4060 year: 2007 end-page: 4064 ident: bib41 article-title: Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T publication-title: Proc Natl Acad Sci U S A – volume: 17 start-page: 383 year: 2007 end-page: 393 ident: bib5 article-title: GEF what? Dock180 and related proteins help Rac to polarize cells in new ways publication-title: Trends Cell Biol – volume: 205 start-page: 1543 year: 2008 end-page: 1550 ident: bib21 article-title: Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells publication-title: J Exp Med – volume: 133 start-page: 1753 year: 2014 end-page: 1755.e3 ident: bib16 article-title: Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-alpha 2b therapy publication-title: J Allergy Clin Immunol – volume: 372 start-page: 2409 year: 2015 end-page: 2422 ident: bib27 article-title: Inherited DOCK2 deficiency in patients with early-onset invasive infections publication-title: N Engl J Med – volume: 205 start-page: 1551 year: 2008 end-page: 1557 ident: bib22 article-title: Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 publication-title: J Exp Med – volume: 5 start-page: 4603 year: 2014 ident: bib43 article-title: DOCK8 regulates protective immunity by controlling the function and survival of RORgammat+ ILCs publication-title: Nat Commun – volume: 280 start-page: 17275 year: 2005 end-page: 17285 ident: bib42 article-title: A role of STAT3 in Rho GTPase-regulated cell migration and proliferation publication-title: J Biol Chem – volume: 153 start-page: 104 year: 2014 end-page: 108 ident: bib15 article-title: Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency publication-title: Clin Immunol – volume: 264 start-page: 95 year: 1994 end-page: 98 ident: bib38 article-title: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 publication-title: Science – volume: 119 start-page: 4451 year: 2012 end-page: 4461 ident: bib7 article-title: DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses publication-title: Blood – volume: 143 start-page: 266 year: 2012 end-page: 272 ident: bib10 article-title: Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait publication-title: Clin Immunol – volume: 124 start-page: 1289 year: 2009 end-page: 1302.e4 ident: bib3 article-title: Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome publication-title: J Allergy Clin Immunol – volume: 134 start-page: 1365 year: 2014 end-page: 1374 ident: bib12 article-title: Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells publication-title: J Allergy Clin Immunol – volume: 122 start-page: 181 year: 2008 end-page: 187 ident: bib24 article-title: Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome publication-title: J Allergy Clin Immunol – volume: 448 start-page: 484 year: 2007 end-page: 487 ident: bib36 article-title: IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells publication-title: Nature – volume: 17 start-page: 4677 year: 1997 end-page: 4686 ident: bib39 article-title: Mutational analysis of acute-phase response factor/Stat3 activation and dimerization publication-title: Mol Cell Biol – volume: 60 start-page: 2126 year: 2004 end-page: 2132 ident: bib25 article-title: Coot: model-building tools for molecular graphics publication-title: Acta Crystallogr D Biol Crystallogr – volume: 12 start-page: 436 year: 2002 end-page: 446 ident: bib32 article-title: Accounting for human polymorphisms predicted to affect protein function publication-title: Genome Res – volume: 22 start-page: 5662 year: 2002 end-page: 5668 ident: bib40 article-title: Identification of a nuclear Stat1 protein tyrosine phosphatase publication-title: Mol Cell Biol – volume: 340 start-page: 692 year: 1999 end-page: 702 ident: bib17 article-title: Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder publication-title: N Engl J Med – volume: 340 start-page: 692 year: 1999 ident: 10.1016/j.jaci.2016.04.023_bib17 article-title: Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder publication-title: N Engl J Med doi: 10.1056/NEJM199903043400904 – volume: 119 start-page: 4451 year: 2012 ident: 10.1016/j.jaci.2016.04.023_bib7 article-title: DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses publication-title: Blood doi: 10.1182/blood-2012-01-407098 – volume: 198 start-page: 1189 year: 2003 ident: 10.1016/j.jaci.2016.04.023_bibE1 article-title: Targeted inactivation of the IL-4 receptor α chain I4R motif promotes allergic airway inflammation publication-title: J Exp Med doi: 10.1084/jem.20030471 – volume: 133 start-page: 1667 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bib13 article-title: Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2014.03.025 – volume: 107 start-page: 21499 year: 2010 ident: 10.1016/j.jaci.2016.04.023_bibE3 article-title: Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1016147107 – volume: 205 start-page: 1551 year: 2008 ident: 10.1016/j.jaci.2016.04.023_bib22 article-title: Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 publication-title: J Exp Med doi: 10.1084/jem.20080218 – volume: 448 start-page: 1058 year: 2007 ident: 10.1016/j.jaci.2016.04.023_bib20 article-title: Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome publication-title: Nature doi: 10.1038/nature06096 – volume: 448 start-page: 484 year: 2007 ident: 10.1016/j.jaci.2016.04.023_bib36 article-title: IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells publication-title: Nature doi: 10.1038/nature05970 – volume: 452 start-page: 773 year: 2008 ident: 10.1016/j.jaci.2016.04.023_bib23 article-title: Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome publication-title: Nature doi: 10.1038/nature06764 – volume: 134 start-page: 221 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bib34 article-title: Flow cytometry diagnosis of dedicator of cytokinesis 8 (DOCK8) deficiency publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2014.02.023 – volume: 124 start-page: 1289 year: 2009 ident: 10.1016/j.jaci.2016.04.023_bib3 article-title: Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.10.038 – volume: 17 start-page: 4677 year: 1997 ident: 10.1016/j.jaci.2016.04.023_bib39 article-title: Mutational analysis of acute-phase response factor/Stat3 activation and dimerization publication-title: Mol Cell Biol doi: 10.1128/MCB.17.8.4677 – volume: 118 start-page: 1 issue: suppl 1 year: 1999 ident: 10.1016/j.jaci.2016.04.023_bib29 article-title: Report of an IUIS Scientific Committee. International Union of Immunological Societies publication-title: Clin Exp Immunol – volume: 147 start-page: 60 year: 2007 ident: 10.1016/j.jaci.2016.04.023_bib28 article-title: Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2006.03251.x – volume: 60 start-page: 2126 year: 2004 ident: 10.1016/j.jaci.2016.04.023_bib25 article-title: Coot: model-building tools for molecular graphics publication-title: Acta Crystallogr D Biol Crystallogr doi: 10.1107/S0907444904019158 – volume: 124 start-page: 1289 year: 2009 ident: 10.1016/j.jaci.2016.04.023_bibE5 article-title: Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.10.038 – volume: 144 start-page: 93 year: 2004 ident: 10.1016/j.jaci.2016.04.023_bib1 article-title: Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity publication-title: J Pediatr doi: 10.1016/S0022-3476(03)00449-9 – volume: 372 start-page: 2409 year: 2015 ident: 10.1016/j.jaci.2016.04.023_bib27 article-title: Inherited DOCK2 deficiency in patients with early-onset invasive infections publication-title: N Engl J Med doi: 10.1056/NEJMoa1413462 – volume: 280 start-page: 17275 year: 2005 ident: 10.1016/j.jaci.2016.04.023_bib42 article-title: A role of STAT3 in Rho GTPase-regulated cell migration and proliferation publication-title: J Biol Chem doi: 10.1074/jbc.M413187200 – volume: 211 start-page: 2549 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bib46 article-title: DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity publication-title: J Exp Med doi: 10.1084/jem.20141307 – volume: 264 start-page: 95 year: 1994 ident: 10.1016/j.jaci.2016.04.023_bib38 article-title: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 publication-title: Science doi: 10.1126/science.8140422 – volume: 104 start-page: 4060 year: 2007 ident: 10.1016/j.jaci.2016.04.023_bib41 article-title: Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0611665104 – year: 2002 ident: 10.1016/j.jaci.2016.04.023_bib26 – volume: 441 start-page: 235 year: 2006 ident: 10.1016/j.jaci.2016.04.023_bib35 article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells publication-title: Nature doi: 10.1038/nature04753 – volume: 22 start-page: 5662 year: 2002 ident: 10.1016/j.jaci.2016.04.023_bib40 article-title: Identification of a nuclear Stat1 protein tyrosine phosphatase publication-title: Mol Cell Biol doi: 10.1128/MCB.22.16.5662-5668.2002 – volume: 190 start-page: 3661 year: 2013 ident: 10.1016/j.jaci.2016.04.023_bib9 article-title: Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity publication-title: J Immunol doi: 10.4049/jimmunol.1202792 – volume: 133 start-page: 1753 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bibE6 article-title: Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-alpha 2b therapy publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2014.03.032 – volume: 205 start-page: 1543 year: 2008 ident: 10.1016/j.jaci.2016.04.023_bib21 article-title: Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells publication-title: J Exp Med doi: 10.1084/jem.20080321 – volume: 131 start-page: 840 year: 2013 ident: 10.1016/j.jaci.2016.04.023_bib8 article-title: Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.12.1568 – volume: 134 start-page: 1365 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bib12 article-title: Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2014.07.042 – volume: 357 start-page: 1608 year: 2007 ident: 10.1016/j.jaci.2016.04.023_bib19 article-title: STAT3 mutations in the hyper-IgE syndrome publication-title: N Engl J Med doi: 10.1056/NEJMoa073687 – volume: 1246 start-page: 26 year: 2011 ident: 10.1016/j.jaci.2016.04.023_bib45 article-title: DOCK8 deficiency publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2011.06295.x – volume: 17 start-page: 383 year: 2007 ident: 10.1016/j.jaci.2016.04.023_bib5 article-title: GEF what? Dock180 and related proteins help Rac to polarize cells in new ways publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2007.05.001 – volume: 153 start-page: 104 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bib15 article-title: Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency publication-title: Clin Immunol doi: 10.1016/j.clim.2014.04.005 – volume: 7 start-page: 248 year: 2010 ident: 10.1016/j.jaci.2016.04.023_bib33 article-title: A method and server for predicting damaging missense mutations publication-title: Nat Methods doi: 10.1038/nmeth0410-248 – volume: 288 start-page: 179 year: 2006 ident: 10.1016/j.jaci.2016.04.023_bib37 article-title: IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain publication-title: Mol Cell Biochem doi: 10.1007/s11010-006-9137-3 – volume: 13 start-page: 612 year: 2012 ident: 10.1016/j.jaci.2016.04.023_bib14 article-title: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation publication-title: Nat Immunol doi: 10.1038/ni.2305 – volume: 325 start-page: 1398 year: 2009 ident: 10.1016/j.jaci.2016.04.023_bib30 article-title: Activation of Rho GTPases by DOCK exchange factors is mediated by a nucleotide sensor publication-title: Science doi: 10.1126/science.1174468 – volume: 361 start-page: 2046 year: 2009 ident: 10.1016/j.jaci.2016.04.023_bib2 article-title: Combined immunodeficiency associated with DOCK8 mutations publication-title: N Engl J Med doi: 10.1056/NEJMoa0905506 – volume: 5 start-page: 4603 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bib43 article-title: DOCK8 regulates protective immunity by controlling the function and survival of RORgammat+ ILCs publication-title: Nat Commun doi: 10.1038/ncomms5603 – volume: 143 start-page: 266 year: 2012 ident: 10.1016/j.jaci.2016.04.023_bib10 article-title: Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait publication-title: Clin Immunol doi: 10.1016/j.clim.2012.03.002 – volume: 133 start-page: 1753 year: 2014 ident: 10.1016/j.jaci.2016.04.023_bib16 article-title: Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-alpha 2b therapy publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2014.03.032 – volume: 136 start-page: 402 year: 2015 ident: 10.1016/j.jaci.2016.04.023_bibE4 article-title: The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2014.12.1945 – volume: 125 start-page: 424 year: 2010 ident: 10.1016/j.jaci.2016.04.023_bib44 article-title: Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.10.059 – volume: 29 start-page: 151 year: 2010 ident: 10.1016/j.jaci.2016.04.023_bib6 article-title: DOCK8 immune deficiency as a model for primary cytoskeletal dysfunction publication-title: Dis Markers doi: 10.1155/2010/397291 – volume: 35 start-page: 189 year: 2015 ident: 10.1016/j.jaci.2016.04.023_bib4 article-title: DOCK8 deficiency: clinical and immunological phenotype and treatment options—a review of 136 patients publication-title: J Clin Immunol doi: 10.1007/s10875-014-0126-0 – volume: 124 start-page: 342 year: 2009 ident: 10.1016/j.jaci.2016.04.023_bib18 article-title: Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.05.004 – volume: 286 start-page: 25341 year: 2011 ident: 10.1016/j.jaci.2016.04.023_bib31 article-title: Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors publication-title: J Biol Chem doi: 10.1074/jbc.M111.236455 – volume: 12 start-page: 436 year: 2002 ident: 10.1016/j.jaci.2016.04.023_bib32 article-title: Accounting for human polymorphisms predicted to affect protein function publication-title: Genome Res doi: 10.1101/gr.212802 – volume: 124 start-page: 342 year: 2009 ident: 10.1016/j.jaci.2016.04.023_bibE2 article-title: Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.05.004 – volume: 122 start-page: 181 year: 2008 ident: 10.1016/j.jaci.2016.04.023_bib24 article-title: Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2008.04.037 – volume: 136 start-page: 402 year: 2015 ident: 10.1016/j.jaci.2016.04.023_bib11 article-title: The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2014.12.1945 |
SSID | ssj0009389 |
Score | 2.4851966 |
Snippet | The autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal dominant HIES... Background The autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal... BACKGROUNDThe autosomal recessive hyper-IgE syndrome (HIES) caused by dedicator of cytokinesis 8 (DOCK8) deficiency shares clinical features with autosomal... |
SourceID | proquest crossref elsevier |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1384 |
SubjectTerms | Bacterial infections Cell division Cell division cycle 42 Crystal structure dedicator of cytokinesis 8 guanine nucleotide exchange factor hyper-IgE syndrome Infections Liver Microscopy mucocutaneous candidiasis Mutation Patients Phosphorylation Proteins signal transducer and activator of transcription 3 suppressor of cytokine signaling 3 TH17 |
Title | Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0091674916303529 https://dx.doi.org/10.1016/j.jaci.2016.04.023 https://www.proquest.com/docview/1837589499 https://www.proquest.com/docview/1826709905 https://www.proquest.com/docview/1846414286 |
Volume | 138 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1faxQxEA-lgvgi_sXTWiL4Jmt383fzWKrlVNqnFvoWkmwCV2XvuNsKvvgB_BR-Fj-ZM7vJiYIn-BLIZiaETDKZ2fxmQsjLVnEwM4KpGE-yEqJLlYnRVK1pvVMpgImPgcJn52p-Kd5fyas9clJiYRBWmXX_pNNHbZ2_HOXZPFotFhjjaxBCDwXHpJ4YxCeExlX--usvmIfh7WQCm6ZC6hw4M2G8rl1YILxLjelOGf_b4fSHmh7PntN75G42GunxNK77ZC_2D8jts3wt_pB8ezNet4D7TJeJhi_D8iOi2Rcb2tL19Nh83FCEakAvA55OHUh0TV3fUQxs-FxYx7aiRygvjVhB2tWI3YOuLuaN_vEdf_rT8sLKMMn4Ebk8fXtxMq_yIwtVkFIOUCafms7VHa-9abhTUgcnNZNM-uSYd7qTGuY3KPBtogncha52tUh17ELy_DHZ75d9fEKoV6zhGgwycPIE08YZYZhmTmnlnWRuRpoyuzbkDOT4EMYnW6Bm1xYlYlEithYWJDIjr7Y8qyn_xk5qXoRmS2Qp6EILx8NOLrnl-m3t_ZPvoKwLm3f-xoKKBBcMU_7MyIttM-xZlInr4_IGaRimzTO13EUjlMB0eOrpfw7vGbmDtSlw8oDsD-ub-BwsqMEfjlvkkNw6fvdhfv4T8hIcnQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEBbpBtpeQn_pJmmrQm_FxNavdQxpg9Nk97SB3IQs27BJ8S67TiGvkKfIs_TJOmNLW1roFnox2KMRQiPNjzXziZCPueLgZniTMN7IRIiqSUxdmyQ3eelU48HFx0LhyVQVl-LrlbzaISexFgbTKoPuH3R6r63Dl6Mwm0fL-RxrfA2m0MODI6ineUR2EZ1Kjsju8dl5Mf2FvcvzwQs2WYIMoXZmSPO6dn6OGV6qRzxl_G_26Q9N3Zuf02dkL_iN9HgY2nOyU7cvyONJOBl_Se4_9ycuEEHTRUP9Xbe4wYT2-ZrmdDXcN1-vKWZrQC8dGqgKhLqirq0o1jZ8j6w9LaoSyiMRX7Dtsk_fg65mRaZ_POB_fxovWekGMb8il6dfZidFEu5ZSLyUsoNnUzZZ5dKKp6XJuFNSeyc1k0yWjWOl05XUMMVeQXhTG8-dr1KXiiatK9-U_DUZtYu2fkNoqVjGNfhkEOcJpo0zwjDNnNKqdJK5Mcni7FofQMjxLoxvNmabXVuUiEWJ2FRYkMiYfNrwLAcIjq2teRSajcWloA4tWIitXHLD9dvy-yffYVwXNmz-tQUtCVEYov6MyYcNGbYtysS19eIW2zBEzjOp3NZGKIGIeGr_P4f3njwpZpMLe3E2PT8gT5Ey1FEeklG3uq3fgkPVle_ChvkJnCIfTg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dedicator+of+cytokinesis+8+regulates+signal+transducer+and+activator+of+transcription+3+activation+and+promotes+TH17+cell+differentiation&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Keles%2C+Sevgi&rft.au=Charbonnier%2C+Louis+Marie&rft.au=Kabaleeswaran%2C+Venkataraman&rft.au=Reisli%2C+Ismail&rft.date=2016-11-01&rft.issn=0091-6749&rft.volume=138&rft.issue=5&rft.spage=1384&rft.epage=1394.e2&rft_id=info:doi/10.1016%2Fj.jaci.2016.04.023&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon |